What does CUSIP 75629V104 represent in this 13F holders report?

CUSIP 75629V104 is the security identifier for RXRX - RECURSION PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held RXRX - RECURSION PHARMACEUTICALS, INC. - Common Stock in Q3 2022?

141 institutional investors reported RXRX - RECURSION PHARMACEUTICALS, INC. - Common Stock for Q3 2022. Use the holders table for investor-level position and value details.

RECURSION PHARMACEUTICALS, INC. - Common Stock (RXRX)

CUSIP: 75629V104

Q3 2022 13F Holders as of 30 Sep 2022

Security type / class: Equity / Common Stock
Total 13F shares: 113,749,582
Total 13F value: $1,210,251,991
Share change: +6,962,794
Put/Call ratio: 32%
SEC-reported price per share: $10.64
Number of holders: 141
Value change: +$75,709,491
Number of buys: 83
Number of sells: 39
Shares outstanding: 525,448,476

Security key

75629V104

Report period

Q3 2022

Institutions

141

Top holders

RXRX full security history Ownership snapshot Full 13F holder table RECURSION PHARMACEUTICALS, INC. SEC filings RECURSION PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of RXRX - RECURSION PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

GENERAL ATLANTIC, L.P.

Disclosed value leader

GENERAL ATLANTIC, L.P.

Comparable rows

15/15

Latest evidence

30 Jun 2022

13F Lead comparable stake: 13% Showing 1-6 of 15 holder rows.

Quick read

GENERAL ATLANTIC, L.P. leads the comparable SEC ownership view at 13%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens GENERAL ATLANTIC, L.P.'s linked filing trail.

Comparable ownership Top 5

GENERAL ATLANTIC, L.P. 13%

Anchorage Capital Group, L.L.C. 13%

VIKING GLOBAL INVESTORS LP 5.2%

Senator Investment Group LP 2.1%

MIC Capital Management UK LLP 1.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
GENERAL ATLANTIC, L.P.	13F Company 13F	13%	$165,257,000 69,435,733 shares	—	30 Jun 2022
Anchorage Capital Group, L.L.C.	13F Company 13F	13%	$164,597,000 69,158,354 shares	—	30 Jun 2022
VIKING GLOBAL INVESTORS LP	13F Company 13F	5.2%	$64,460,000 27,084,126 shares	—	30 Jun 2022
Senator Investment Group LP	13F Company 13F	2.1%	$22,950,000 11,135,257 shares	—	30 Jun 2022
MIC Capital Management UK LLP	13F Company 13F	1.6%	$68,798,000 8,451,758 shares	—	30 Jun 2022
COATUE MANAGEMENT LLC	13F Company 13F	1.5%	$18,892,000 7,937,724 shares	—	30 Jun 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

141

113,749,582

Rows available

141

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

130

Q3 2022 holders

141

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 value	Q3 2022 value	Value change	Value Chg %